None listed
Conditions
Interventions
Drug : Participants will be randomized in a 1:1 ratio to receive monitored anesthesia care (MAC) with remimazolam combined with either sufentanil or remifentanil. Remifentanil and sufentanil will be a
Sponsors
Seoul National University Bundang Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Adult patients aged =19 years undergoing surgery under monitored anesthesia care (MAC)
Exclusion criteria
Exclusion criteria: Preexisting renal or hepatic dysfunction Pregnancy Known hypersensitivity or adverse reactions to remimazolam, remifentanil, or sufentanil
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| surgical condition | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of intraoperative hypotension and apnea;Postoperative pain score ;Incidence of nausea and vomiting during the recovery period;Analgesic consumption in the PACU;Administration of reversal agents (flumazenil and naloxone);ncidence of unplanned events requiring conversion to general anesthesia or unplanned admission;Patient satisfaction with the overall anesthesia experience | — |
Countries
Korea, Republic of
Contacts
Public ContactJiyoun Lee
Seoul National University Bundang Hospital
Outcome results
None listed